刘雪洁;赵天旖;袁丽芳;舒跃龙;

• 1:中山大学公共卫生学院(深圳)

摘要(Abstract)：

接种流感疫苗是预防和控制流感最为有效的措施。流感病毒由于其宿主多样、亚型众多,流感疫苗的有效性十分受限,同时由于其具有高度的变异性,一旦有较大的变异或新亚型的流感病毒出现,现有疫苗就会失效,因此研制能够通过免疫交叉反应对变异较大或多种亚型的流感病毒提供广泛保护的通用型流感疫苗迫在眉睫。

关键词(KeyWords)： 流感病毒;流感疫苗;通用疫苗

Abstract:

Keywords:

基金项目(Foundation): 国家杰出青年科学基金（项目号：81525017），题目：流感病原生物学研究~~

作者(Author): 刘雪洁;赵天旖;袁丽芳;舒跃龙;

Email:

DOI: 10.13242/j.cnki.bingduxuebao.003869

参考文献(References)：

• [1]Iuliano A D,Roguski K M,Chang H H,Muscatello DJ,Palekar R,Tempia S,Cohen C,Gran J M,Schanzer D,Cowling B J,Wu P,Kyncl J,Ang L W,Park M,Redlberger-Fritz M,Yu H,Espenhain L,Krishnan A,Emukule G,van Asten L,Pereira da Silva S,Aungkulanon S,Buchholz U,Widdowson M-A,Bresee J S,Azziz-Baumgartner E,Cheng P-Y,Dawood F,Foppa I,Olsen S,Haber M,Jeffers C,Mac Intyre C R,Newall A T,Wood J G,Kundi M,Popow-Kraupp T,Ahmed M,Rahman M,Marinho F,Sotomayor Proschle C V,Vergara Mallegas N,Luzhao F,Sa L,Barbosa-Ramírez J,Sanchez D M,Gomez LA,Vargas X B,Acosta Herrera a,Llanés M J,Fischer T K,Krause T G,M?lbak K,Nielsen J,Trebbien R,Bruno A,Ojeda J,Ramos H,an der Heiden M,del Carmen Castillo Signor L,Serrano C E,Bhardwaj R,Chadha M,Narayan V,Kosen S,Bromberg M,Glatman-Freedman A,Kaufman Z,Arima Y,Oishi K,Chaves S,Nyawanda B,Al-Jarallah R A,Kuri-Morales P A,Matus C R,Corona M E J,Burmaa A,Darmaa O,Obtel M,Cherkaoui I,van den Wijngaard C C,van der Hoek W,Baker M,Bandaranayake D,Bissielo A,Huang S,Lopez L,Newbern C,Flem E,Gr?neng GM,Hauge S,de Cosío F G,de MoltóY,Castillo LM,Cabello M A,von Horoch M,Medina Osis J,Machado A,Nunes B,Rodrigues A P,Rodrigues E,Calomfirescu C,Lupulescu E,Popescu R,Popovici O,Bogdanovic D,Kostic M,Lazarevic K,Milosevic Z,Tiodorovic B,Chen M,Cutter J,Lee V,Lin R,Ma S,Cohen A L,Treurnicht F,Kim W J,Delgado-Sanz C,de mateo Onta?ón S,Larrauri A,León I L,Vallejo F,Born R,Junker C,Koch D,Chuang J-H,Huang W-T,Kuo H-W,Tsai Y-C,Bundhamcharoen K,Chittaganpitch M,Green H K,Pebody R,Go?i N,Chiparelli H,Brammer L,Mustaquim D.Estimates of global seasonal influenza-associated respiratory mortality:a modelling study[J].Lancet,2018,391(10127):1285-1300.
• [2]郑建东，张慕丽，彭质斌，秦颖，冯录召.中国2014-2018年法定报告流感确诊发病和死亡病例分析[J].国际病毒学杂志，2020,1:6-10.
• [3]Lopez C E,Legge K L.Influenza A virus vaccination:Immunity,protection,and recent advances toward a universal vaccine[J].Vaccines(Basel),2020,8(3):434.
• [4]Wille M,Holmes E C.The ecology and evolution of influenza viruses[J].Cold Spring Harb Perspect Med,2020,10(7):a038489.
• [5]Hause B M,Ducatez M,Collin E A,Ran Z,Liu R,Sheng Z,Armien A,Kaplan B,Chakravarty S,Hoppe A D,Webby R J,Simonson R R,Li F.Isolation of a novel swine influenza virus from Oklahoma in 2011which is distantly related to human influenza C viruses[J/OL].PLo S Pathog,2013,9(2):e1003176.
• [6]马保华，邓文喻，李贺.D型流感病毒概述[J].贵州畜牧兽医，2020,44(2):46-48.
• [7]Zhang Z,Zhang H,Xu L,Guo X,Wang W,Ji Y,Lin C,Wang Y,Wang X.Selective usage of ANP32proteins by influenza B virus polymerase:Implications in determination of host range[J/OL].PLo S Pathog,2020,16(10):e1008989.
• [8]Taubenberger J K,Kash J C.Influenza virus evolution,host adaptation,and pandemic formation[J].Cell Host Microbe,2010,7(6):440-451.
• [9]Wu N C,Wilson I A.Influenza hemagglutinin structures and antibody recognition[J].Cold Spring Harb Perspect Med,2020,10(8):a038778.
• [10]Keshavarz M,Mirzaei H,Salemi M,Momeni F,Mousavi M J,Sadeghalvad M,Arjeini Y,SolaymaniMohammadi F,Sadri Nahand J,Namdari H,MokhtariAzad T,Rezaei F.Influenza vaccine:Where are we and where do we go?[J/OL].Rev Med Virol,2019,29(1):e2014.
• [11]Khalaj-Hedayati A,Chua C L L,Smooker P,Lee KW.Nanoparticles in influenza subunit vaccine development:Immunogenicity enhancement[J].Influenza Other Respir Viruses,2020,14(1):92-101.
• [12]Korenkov D,Isakova-Sivak I,Rudenko L.Basics of CD8 T-cell immune responses after influenza infection and vaccination with inactivated or live attenuated influenza vaccine[J].Expert Rev Vaccines,2018,17(11):977-987.
• [13]Wang W,Song H S,Keller P W,Alvarado-Facundo E,Vassell R,Weiss C D.Conformational stability of the hemagglutinin of H5N1 influenza A viruses influences susceptibility to broadly neutralizing stem antibodies[J/OL].J Virol,2018,92(12):e00247-18.
• [14]Bullough P A,Hughson F M,Skehel J J,Wiley D C.Structure of influenza haemagglutinin at the p H of membrane fusion[J].Nature,1994,371(6492):37-43.
• [15]Wilson I A,Skehel J J,Wiley D C.Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution[J].Nature,1981,289(5796):366-373.
• [16]Skehel J J,Wiley D C.Receptor binding and membrane fusion in virus entry:the influenza hemagglutinin[J].Annu Rev Biochem,2000,69:531-569.
• [17]Chaipan C,Kobasa D,Bertram S,Glowacka I,Steffen I,Tsegaye T S,Takeda M,Bugge T H,Kim S,Park Y,Marzi A,Pohlmann S.Proteolytic activation of the1918 influenza virus hemagglutinin[J].J Virol,2009,83(7):3200-3211.
• [18]Quinones-Parra S,Loh L,Brown L E,Kedzierska K,Valkenburg S A.Universal immunity to influenza must outwit immune evasion[J].Front Microbiol,2014,5:285.
• [19]Hensley S E,Das S R,Bailey A L,Schmidt L M,Hickman H D,Jayaraman A,Viswanathan K,Raman R,Sasisekharan R,Bennink J R,Yewdell J W.Hemagglutinin receptor binding avidity drives influenza A virus antigenic drift[J].Science,2009,326(5953):734-736.
• [20]Yewdell J W,Caton A J,Gerhard W.Selection of influenza A virus adsorptive mutants by growth in the presence of a mixture of monoclonal antihemagglutinin[J].J Virol,1986,57(2):623-628.
• [21]Friesen R H,Lee P S,Stoop E J,Hoffman R M,Ekiert D C,Bhabha G,Yu W,Juraszek J,Koudstaal W,Jongeneelen M,Korse H J,Ophorst C,Brinkmanvan der Linden E C,Throsby M,Kwakkenbos M J,Bakker A Q,Beaumont T,Spits H,Kwaks T,Vogels R,Ward A B,Goudsmit J,Wilson I A.A common solution to group 2 influenza virus neutralization[J].Proc Natl Acad Sci U S A,2014,111(1):445-450.
• [22]Corti D,Voss J,Gamblin S J,Codoni G,Macagno A,Jarrossay D,Vachieri S G,Pinna D,Minola A,Vanzetta F,Silacci C,Fernandez-Rodriguez B M,Agatic G,Bianchi S,Giacchetto-Sasselli I,Calder L,Sallusto F,Collins P,Haire L F,Temperton N,Langedijk J P,Skehel J J,Lanzavecchia A.Aneutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins[J].Science,2011,333(6044):850-856.
• [23]Throsby M,van den Brink E,Jongeneelen M,Poon LL,Alard P,Cornelissen L,Bakker A,Cox F,van Deventer E,Guan Y,Cinatl J,ter Meulen J,Lasters I,Carsetti R,Peiris M,de Kruif J,Goudsmit J.Heterosubtypic neutralizing monoclonal antibodies crossprotective against H5N1 and H1N1 recovered from human Ig M+memory B cells[J/OL].PLo S One,2008,3(12):e3942.
• [24]Ekiert D C,Friesen R H,Bhabha G,Kwaks T,Jongeneelen M,Yu W,Ophorst C,Cox F,Korse H J,Brandenburg B,Vogels R,Brakenhoff J P,Kompier R,Koldijk M H,Cornelissen L A,Poon L L,Peiris M,Koudstaal W,Wilson I A,Goudsmit J.A highly conserved neutralizing epitope on group 2 influenza Aviruses[J].Science,2011,333(6044):843-850.
• [25]Kashyap A K,Steel J,Oner A F,Dillon M A,Swale R E,Wall K M,Perry K J,Faynboym A,Ilhan M,Horowitz M,Horowitz L,Palese P,Bhatt R R,Lerner R A.Combinatorial antibody libraries from survivors of the Turkish H5N1 avian influenza outbreak reveal virus neutralization strategies[J].Proc Natl Acad Sci U S A,2008,105(16):5986-5991.
• [26]Biswas M,Yamazaki T,Chiba J,Akashi-Takamura S.Broadly neutralizing antibodies for influenza:Passive immunotherapy and intranasal vaccination[J].Vaccines(Basel),2020,8(3):424.
• [27]Kanekiyo M,Wei C J,Yassine H M,Mc Tamney PM,Boyington J C,Whittle J R,Rao S S,Kong W P,Wang L,Nabel G J.Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1antibodies[J].Nature,2013,499(7456):102-106.
• [28]Caton A J,Brownlee G G,Yewdell J W,Gerhard W.The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin(H1 subtype)[J].Cell,1982,31(2Pt 1):417-427.
• [29]Ekiert D C,Bhabha G,Elsliger M A,Friesen R H,Jongeneelen M,Throsby M,Goudsmit J,Wilson I A.Antibody recognition of a highly conserved influenza virus epitope[J].Science,2009,324(5924):246-251.
• [30]Corti D,Suguitan A L Jr,Pinna D,Silacci C,Fernandez-Rodriguez B M,Vanzetta F,Santos C,Luke C J,Torres-Velez F J,Temperton N J,Weiss RA,Sallusto F,Subbarao K,Lanzavecchia A.Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine[J].J Clin Invest,2010,120(5):1663-1673.
• [31]Wang T T,Tan G S,Hai R,Pica N,Petersen E,Moran T M,Palese P.Broadly protective monoclonal antibodies against H3 influenza viruses following sequential immunization with different hemagglutinins[J/OL].PLo S Pathog,2010,6(2):e1000796.
• [32]Sui J,Hwang W C,Perez S,Wei G,Aird D,Chen LM,Santelli E,Stec B,Cadwell G,Ali M,Wan H,Murakami A,Yammanuru A,Han T,Cox N J,Bankston L A,Donis R O,Liddington R C,Marasco W A.Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses[J].Nat Struct Mol Biol,2009,16(3):265-273.
• [33]Wang W,Anderson C M,De Feo C J,Zhuang M,Yang H,Vassell R,Xie H,Ye Z,Scott D,Weiss CD.Cross-neutralizing antibodies to pandemic 2009 H1N1and recent seasonal H1N1 influenza A strains influenced by a mutation in hemagglutinin subunit 2[J/OL].PLo SPathog,2011,7(6):e1002081.
• [34]Wang T T,Tan G S,Hai R,Pica N,Ngai L,Ekiert D C,Wilson I A,Garcia-Sastre A,Moran T M,Palese P.Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypes[J].Proc Natl Acad Sci U S A,2010,107(44):18979-18984.
• [35]Wiley D C,Wilson I A,Skehel J J.Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation[J].Nature,1981,289(5796):373-378.
• [36]Bommakanti G,Citron M P,Hepler R W,Callahan C,Heidecker G J,Najar T A,Lu X,Joyce J G,Shiver JW,Casimiro D R,ter Meulen J,Liang X,Varadarajan R.Design of an HA2-based Escherichia coli expressed influenza immunogen that protects mice from pathogenic challenge[J].Proc Natl Acad Sci U S A,2010,107(31):13701-13706.
• [37]Smrt S T,Lorieau J L.Membrane fusion and infection of the influenza hemagglutinin[J].Adv Exp Med Biol,2017,966:37-54.
• [38]Hashem A M.Prospects of HA-based universal influenza vaccine[J].Biomed Res Int,2015,2015:414637.
• [39]Doud M B,Bloom J D.Accurate measurement of the effects of all amino-acid mutations on influenza hemagglutinin[J].Viruses,2016,8(6):155.
• [40]Thyagarajan B,Bloom J D.The inherent mutational tolerance and antigenic evolvability of influenza hemagglutinin[J/OL].Elife,2014,3:e03300.
• [41]Heaton N S,Sachs D,Chen C J,Hai R,Palese P.Genome-wide mutagenesis of influenza virus reveals unique plasticity of the hemagglutinin and NS1 proteins[J].Proc Natl Acad Sci U S A,2013,110(50):20248-20253.
• [42]Joyce M G,Wheatley A K,Thomas P V,Chuang GY,Soto C,Bailer R T,Druz A,Georgiev I S,Gillespie R A,Kanekiyo M,Kong W P,Leung K,Narpala S N,Prabhakaran M S,Yang E S,Zhang B,Zhang Y,Asokan M,Boyington J C,Bylund T,Darko S,Lees C R,Ransier A,Shen C H,Wang L,Whittle J R,Wu X,Yassine H M,Santos C,Matsuoka Y,Tsybovsky Y,Baxa U,Program N C S,Mullikin J C,Subbarao K,Douek D C,Graham B S,Koup R A,Ledgerwood J E,Roederer M,Shapiro L,Kwong P D,Mascola J R,Mc Dermott A B.Vaccine-induced antibodies that neutralize group 1 and group 2 influenza A viruses[J].Cell,2016,166(3):609-623.
• [43]Wu Y,Cho M,Shore D,Song M,Choi J,Jiang T,Deng Y Q,Bourgeois M,Almli L,Yang H,Chen LM,Shi Y,Qi J,Li A,Yi K S,Chang M,Bae J S,Lee H,Shin J,Stevens J,Hong S,Qin C F,Gao GF,Chang S J,Donis R O.A potent broad-spectrum protective human monoclonal antibody crosslinking two haemagglutinin monomers of influenza A virus[J].Nat Commun,2015,6:7708.
• [44]Kallewaard N L,Corti D,Collins P J,Neu U,Mc Auliffe J M,Benjamin E,Wachter-Rosati L,Palmer-Hill F J,Yuan A Q,Walker P A,Vorlaender M K,Bianchi S,Guarino B,De Marco A,Vanzetta F,Agatic G,Foglierini M,Pinna D,Fernandez-Rodriguez B,Fruehwirth A,Silacci C,Ogrodowicz R W,Martin S R,Sallusto F,Suzich J A,Lanzavecchia A,Zhu Q,Gamblin S J,Skehel J J.Structure and function analysis of an antibody recognizing all influenza A subtypes[J].Cell,2016,166(3):596-608.
• [45]Najar T A,Kar U,Flynn J A,Varadarajan R.Isolation of an in vitro affinity-matured,thermostable"headless"HA stem fragment that binds broadly neutralizing antibodies with high affinity[J].Biochemistry,2018,57(26):3817-3829.
• [46]Impagliazzo A,Milder F,Kuipers H,Wagner M V,Zhu X,Hoffman R M,van Meersbergen R,Huizingh J,Wanningen P,Verspuij J,de Man M,Ding Z,Apetri A,Kükrer B,Sneekes-Vriese E,Tomkiewicz D,Laursen N S,Lee P S,Zakrzewska A,Dekking L,Tolboom J,Tettero L,van Meerten S,Yu W,Koudstaal W,Goudsmit J,Ward A B,Meijberg W,Wilson I A,Rado?evi?K.A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen[J].Science,2015,349(6254):1301-1306.
• [47]Krammer F,Pica N,Hai R,Margine I,Palese P.Chimeric hemagglutinin influenza virus vaccine constructs elicit broadly protective stalk-specific antibodies[J].J Virol,2013,87(12):6542-6550.
• [48]Zost S J,Wu N C,Hensley S E,Wilson I A.Immunodominance and antigenic variation of influenza virus hemagglutinin:Implications for design of universal vaccine immunogens[J].J Infect Dis,2019,219(Suppl_1):S38-S45.
• [49]Bonsignori M,Liao H X,Gao F,Williams W B,Alam S M,Montefiori D C,Haynes B F.Antibody-virus coevolution in HIV infection:paths for HIV vaccine development[J].Immunol Rev,2017,275 (1):145-160.
• [50]Landais E,Murrell B,Briney B,Murrell S,Rantalainen K,Berndsen Z T,Ramos A,Wickramasinghe L,Smith M L,Eren K,de Val N,Wu M,Cappelletti A,Umotoy J,Lie Y,Wrin T,Algate P,Chan-Hui P Y,Karita E,Investigators I PC,Network I A H R,Ward A B,Wilson I A,Burton D R,Smith D,Pond S L K,Poignard P.HIVEnvelope Glycoform Heterogeneity and Localized Diversity Govern the Initiation and Maturation of a V2Apex Broadly Neutralizing Antibody Lineage[J/OL].Immunity,2017,47(5):990-1003.e9.
• [51]Stadlbauer D,Zhu X,Mc Mahon M,Turner J S,Wohlbold T J,Schmitz A J,Strohmeier S,Yu W,Nachbagauer R,Mudd P A,Wilson I A,Ellebedy AH,Krammer F.Broadly protective human antibodies that target the active site of influenza virus neuraminidase[J].Science,2019,366(6464):499-504.
• [52]Giurgea L T,Morens D M,Taubenberger J K,Memoli M J.Influenza neuraminidase:A neglected protein and its potential for a better influenza vaccine[J].Vaccines(Basel),2020,8(3):409.
• [53]Chen Y Q,Wohlbold T J,Zheng N Y,Huang M,Huang Y,Neu K E,Lee J,Wan H,Rojas K T,Kirkpatrick E,Henry C,Palm A E,Stamper C T,Lan L Y,Topham D J,Treanor J,Wrammert J,Ahmed R,Eichelberger M C,Georgiou G,Krammer F,Wilson P C.Influenza infection in humans induces broadly cross-reactive and protective neuraminidasereactive antibodies[J/OL].Cell,2018,173(2):417-429.e10.
• [54]Wohlbold T J,Podolsky K A,Chromikova V,Kirkpatrick E,Falconieri V,Meade P,Amanat F,Tan J,ten Oever B R,Tan G S,Subramaniam S,Palese P,Krammer F.Broadly protective murine monoclonal antibodies against influenza B virus target highly conserved neuraminidase epitopes[J].Nat Microbiol,2017,2(10):1415-1424.
• [55]Smith G E,Sun X,Bai Y,Liu Y V,Massare M J,Pearce M B,Belser J A,Maines T R,Creager H M,Glenn G M,Flyer D,Pushko P,Levine M Z,Tumpey T M.Neuraminidase-based recombinant virus-like particles protect against lethal avian influenza A(H5N1)virus infection in ferrets[J].Virology,2017,509:90-97.
• [56]Mc Geoch D,Fellner P,Newton C.Influenza virus genome consists of eight distinct RNA species[J].Proc Natl Acad Sci U S A,1976,73(9):3045-3049.
• [57]Winter G,Fields S.Cloning of influenza c DNA ino M13:the sequence of the RNA segment encoding the A/PR/8/34 matrix protein[J].Nucleic Acids Res,1980,8:1965-1974.
• [58]Lamb R A,Lai C J.Conservation of the influenza virus membrane protein (M1) amino acid sequence and an open reading frame of RNA segment 7 encoding a second protein (M2) in H1N1 and H3N2 strains[J].Virology,1981,112(2):746-751.
• [59]Lamb R A,Choppin P W.Identification of a second protein(M2) encoded by RNA segment 7 of influenza virus[J].Virology 1981,112(2):729-737.
• [60]Zebedee S L,Lamb R A.Influenza A virus M2 protein:monoclonal antibody restriction of virus growth and detection of M2 in virions[J].J Virol,1988,62(8):2762-2772.
• [61]Wang R,Song A,Levin J,Dennis D,Zhang N J,Yoshida H,Koriazova L,Madura L,Shapiro L,Matsumoto A,Yoshida H,Mikayama T,Kubo R T,Sarawar S,Cheroutre H,Kato S.Therapeutic potential of a fully human monoclonal antibody against influenza Avirus M2 protein[J].Antiviral Res,2008,80(2):168-177.
• [62]Fernandez-Sesma A,Schulman JL,Moran TM.Abispecific antibody recognizing influenza A virus M2protein redirects effector cells to inhibit virus replication in vitro[J].J Viro,1996,70(7):4800-4804.
• [63]Ebrahimi S M,Tebianian M,Toghyani H,Memarnejadian A,Attaran H R.Cloning,expression and purification of the influenza A (H9N2) virus M2e antigen and truncated Mycobacterium tuberculosis HSP70 as a fusion protein in Pichia pastoris[J].Protein Expr Purif,2010,70(1):7-12.
• [64]Farahmand B,Taheri N,Shokouhi H,Soleimanjahi H,Fotouhi F.Chimeric protein consisting of 3M2e and HSP as a universal influenza vaccine candidate:from in silico analysis to preliminary evaluation[J].Virus Genes,2019,55(1):22-32.
• [65]Ng A K,Wang J H,Shaw P C.Structure and sequence analysis of influenza A virus nucleoprotein[J].Sci China C Life Sci,2009,52(5):439-449.
• [66]Yewdell J W,Bennink J R,Smith G L,Moss B.Influenza A virus nucleoprotein is a major target antigen for cross-reactive anti-influenza A virus cytotoxic Tlymphocytes[J].Proc Natl Acad Sci U S A,1985,82(6):1785-1789.
• [67]Lo C Y,Tang Y S,Shaw P C.Structure and function of influenza virus ribonucleoprotein[J].Subcell Biochem,2018,88:95-128.
• [68]Thomas P G,Keating R,Hulse-Post D J,Doherty PC.Cell-mediated protection in influenza infection[J].Emerg Infect Dis,2006,12(1):48-54.
• [69]Alexander J,Bilsel P,del Guercio M F,Stewart S,Marinkovic-Petrovic A,Southwood S,Crimi C,Vang L,Walker L,Ishioka G,Chitnis V,Sette A,Assarsson E,Hannaman D,Botten J,Newman M J.Universal influenza DNA vaccine encoding conserved CD4+T cell epitopes protects against lethal viral challenge in HLA-DR transgenic mice[J].Vaccine,2010,28(3):664-672.
• [70]Zheng M,Luo J,Chen Z.Development of universal influenza vaccines based on influenza virus M and NPgenes[J].Infection,2014,42(2):251-262.
• [71]Green M,Loewenstein P M.Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein[J].Cell,1988,55(6):1179-1188.
• [72]Yin Y,Li B,Zhou L,Luo J,Liu X,Wang S,Lu Q,Tan W,Chen Z.Protein transduction domain-mediated influenza NP subunit vaccine generates a potent immune response and protection against influenza virus in mice[J].Emerg Microbes Infect,2020,9(1):1933-1942.
• [73]Hessel A,Savidis-Dacho H,Coulibaly S,Portsmouth D,Kreil T R,Crowe B A,Schwendinger M G,Pilz A,Barrett P N,Falkner F G,Schafer B.MVA vectors expressing conserved influenza proteins protect mice against lethal challenge with H5N1,H9N2 and H7N1viruses[J/OL].PLo S One,2014,9(2):e88340.
• [74]Wang Y,Chen L,Cheng Y,Zhou S,Pang Y,Zhang J,Greene C M,Song Y,Zhang T,Zhao G.Potential impact of B lineage mismatch on trivalent influenza vaccine effectiveness during the 2015-2016 influenza season among nursery school children in Suzhou,China[J].Hum Vaccin Immunother,2018,14(3):630-636.
• [75]Calzas C,Chevalier C.Innovative mucosal vaccine formulations against influenza A virus infections[J].Front Immunol,2019,10:1605.
• [76]Knight F C,Gilchuk P,Kumar A,Becker K W,Sevimli S,Jacobson M E,Suryadevara N,WangBishop L,Boyd K L,Crowe J E Jr,Joyce S,Wilson JT.Mucosal immunization with a p H-responsive nanoparticle vaccine induces protective CD8(+)lungresident memory T cells[J].ACS Nano,2019,13(10):10939-10960.
• [77]Dhakal S,Renu S,Ghimire S,Shaan Lakshmanappa Y,Hogshead B T,Feliciano-Ruiz N,Lu F,Hogen Esch H,Krakowka S,Lee C W,Renukaradhya G J.Mucosal immunity and protective efficacy of intranasal inactivated influenza vaccine is improved by chitosan nanoparticle delivery in pigs[J].Front Immunol,2018,9:934.
• [78]Wang T,Wei F,Liu J.Emerging role of mucosal vaccine in preventing infection with avian influenza Aviruses[J].Viruses,2020,12(8):862.
• [79]Hinkula J,Nystrom S,Devito C,Brave A,Applequist S E.Long-lasting mucosal and systemic immunity against influenza A virus is significantly prolonged and protective by nasal whole influenza immunization with mucosal adjuvant N3 and DNA-plasmid expressing flagellin in aging in-and outbred mice[J].Vaccines(Basel),2019,7(3):64.
• [